BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24022725)

  • 1. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
    Lee JL; Redzuan AM; Shah NM
    Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
    Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
    Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study.
    Oguz SS; Kanmaz HG; Dilmen U
    Int J Clin Pharm; 2012 Feb; 34(1):136-41. PubMed ID: 22234653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit.
    Gidey MT; Gebretsadkan YG; Tsadik AG; Welie AG; Assefa BT
    Ital J Pediatr; 2020 Apr; 46(1):41. PubMed ID: 32245504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU).
    Jobanputra N; Save SU; Bavdekar SB
    Int J Risk Saf Med; 2015; 27(3):113-21. PubMed ID: 26410245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.
    Laforgia N; Nuccio MM; Schettini F; Dell'Aera M; Gasbarro AR; Dell'Erba A; Solarino B
    Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
    Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
    Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study.
    Kieran EA; O'Callaghan N; O'Donnell CP
    Acta Paediatr; 2014 Apr; 103(4):e139-42. PubMed ID: 24397831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
    Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
    García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
    An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory drugs prescribed off-label among children in the outpatient clinics of a hospital in Malaysia.
    Mohamad NF; Mhd Ali A; Mohamed Shah N
    Int J Clin Pharm; 2015 Feb; 37(1):127-32. PubMed ID: 25488318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine.
    Khdour MR; Hallak HO; Alayasa KS; AlShahed QN; Hawwa AF; McElnay JC
    Int J Clin Pharm; 2011 Aug; 33(4):650-5. PubMed ID: 21567279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.
    Palčevski G; Skočibušić N; Vlahović-Palčevski V
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1073-7. PubMed ID: 22307225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
    Borges AP; Campos MS; Pereira LR
    Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.
    Cuzzolin L; Agostino R
    Eur J Clin Pharmacol; 2016 Jan; 72(1):117-23. PubMed ID: 26490354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
    Ellul IC; Grech V; Attard-Montalto S
    Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study.
    Mazhar F; Akram S; Haider N; Hadi MA; Sultana J
    Int J Clin Pharm; 2018 Jun; 40(3):700-703. PubMed ID: 29721741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit.
    Arocas Casañ V; Cabezuelo Escribano B; Garrido-Corro B; De la Cruz Murie P; Blázquez Álvarez MJ; De la Rubia Nieto MªA
    Farm Hosp; 2017 May; 41(3):371-381. PubMed ID: 28478751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.